Fludeoxyglucose f18

Fludeoxyglucose F18 is a radioactive diagnostic agent used in positron emission tomography (PET) scans to help detect and evaluate conditions like cancer. It's administered intravenously as an injection, with a strength of up to 300 mCi/mL. Manufactured by MIPS Cyclotron & Radiochemistry Facility, it's a prescription drug approved as a generic equivalent. This information was generated using AI and is provided for informational and research purposes only.